Cargando…
Extracellular vesicles from Lactobacillus druckerii inhibit hypertrophic scar fibrosis
BACKGROUND: Hypertrophic scars (HS) affect millions of people each year and require better treatment strategies. Bacterial extracellular vesicles (EVs) are advantaged by low cost and high yield which was commonly used in the treatment of diseases. Here, we investigated the therapeutic efficacy of EV...
Autores principales: | Han, Fu, Wang, Kejia, Shen, Kuo, Wang, Jing, Han, Shichao, Hu, Dahai, Wu, Gaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053340/ https://www.ncbi.nlm.nih.gov/pubmed/36978136 http://dx.doi.org/10.1186/s12951-023-01861-y |
Ejemplares similares
-
Adiponectin ameliorates hypertrophic scar by inhibiting Yes-associated protein transcription through SIRT1-mediated deacetylation of C/EBPβ and histone H3
por: Zhang, Jian, et al.
Publicado: (2022) -
KLF4 Alleviates Hypertrophic Scar Fibrosis by Directly Activating BMP4 Transcription
por: Wang, Jing, et al.
Publicado: (2022) -
The Akt/FoxO/p27(Kip1) axis contributes to the anti‐proliferation of pentoxifylline in hypertrophic scars
por: Yang, Fangfang, et al.
Publicado: (2019) -
Extracellular Vesicles in Corneal Fibrosis/Scarring
por: Yeung, Vincent, et al.
Publicado: (2022) -
Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway
por: Li, Yan, et al.
Publicado: (2016)